Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Total Revenue | 24.67 | 26.91 | 16.95 | 10.95 | - |
Total Expenses | 21.93 | 25.86 | 16.73 | 10.82 | - |
Profit Before Tax | 2.74 | 1.05 | 0.22 | 0.14 | - |
Profit After Tax | 2.04 | 0.78 | 0.17 | 0.04 | - |
Operating Profit after Depreciation | 2.80 | 1.07 | 0.23 | 0.14 | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Fixed Assets | 0.35 | 0.47 | 0.15 | 0.03 | - |
Total Non Current Assets | 0.41 | 0.50 | 0.16 | 0.03 | - |
Total Current Assets | 16.30 | 12.52 | 9.32 | 6.22 | - |
TOTAL ASSETS | 16.71 | 13.02 | 9.48 | 6.25 | - |
Total Shareholder's Fund | 3.11 | 1.07 | 0.29 | 0.13 | - |
Particulars (in ₹ Cr.) | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 1.15 | -0.44 | 0.15 | -0.90 | - |
Net Cash used in Investing Activities | -0.03 | -0.36 | -0.16 | -0.01 | - |
Net Cash used in Financing Activities | -1.15 | 0.90 | 0.04 | 1.11 | - |
No data available
Particulars (in ₹ Cr.) | 2023-09 | 2023-06 | 2023-03 |
---|---|---|---|
Total Revenue | - | 5.64 | - |
Total Expenses | - | 4.64 | - |
Profit Before Tax | - | 0.97 | - |
Profit After Tax | 1.23 | 0.75 | -0.32 |
Operating Profit after Depreciation | - | 1 | - |
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Sunrest Lifescience Ltd | ₹55 | ₹23.60 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
07 Nov 2024, 03:31 pm
09 Sep 2024, 05:42 pm
20 May 2024, 03:59 pm
18 Jan 2024, 03:44 pm
20 Nov 2023, 11:39 am